SEC Comment Letter for Cyclerion Therapeutics, Inc. (CYCN) (CIK 0001755237) (KRSA) — Apr 16, 2019
Cyclerion Therapeutics, Inc. (CYCN) (CIK 0001755237)
Date: April 16, 2019 · CIK: 0001755237 · Accession: 0000000000-19-007200
AI Filing Summary & Sentiment
Letter
April 16, 2019 Peter M. Hecht, Ph.D. Chief Executive Officer Cyclerion Therapeutics, Inc. 301 Binney Street Cambridge, MA 02142 Re:Cyclerion Therapeutics, Inc. Draft Registration Statement on Form S-1 Submitted April 9, 2019 CIK No. 0001755237 Dear Dr. Hecht: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement no later than 48 hours prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at 202-551-5019 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Bryan S. Keighery, Esq.
Show Raw Text
April 16, 2019
Peter M. Hecht, Ph.D.
Chief Executive Officer
Cyclerion Therapeutics, Inc.
301 Binney Street
Cambridge, MA 02142
Re:Cyclerion Therapeutics, Inc.
Draft Registration Statement on Form S-1
Submitted April 9, 2019
CIK No. 0001755237
Dear Dr. Hecht:
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement no later than 48 hours prior
to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
Please contact Christine Westbrook at 202-551-5019 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Bryan S. Keighery, Esq.